| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 14.40▼ | 14.54▼ | 14.47▼ | 14.49▼ | 14.11▲ |
| MA10 | 14.50▼ | 14.47▼ | 14.44▼ | 14.11▲ | 14.87▼ |
| MA20 | 14.48▼ | 14.44▼ | 14.55▼ | 14.06▲ | 16.22▼ |
| MA50 | 14.45▼ | 14.57▼ | 14.26▲ | 15.20▼ | 21.24▼ |
| MA100 | 14.53▼ | 14.18▲ | 14.31▲ | 16.60▼ | 21.71▼ |
| MA200 | 14.59▼ | 14.29▲ | 14.35▼ | 20.96▼ | 24.97▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.024▼ | 0.007▲ | -0.030▼ | 0.124▲ | 0.106▲ |
| RSI | 40.302▼ | 41.831▼ | 45.722▼ | 48.114▼ | 41.336▼ |
| STOCH | 9.631▼ | 57.956 | 34.995 | 68.053 | 31.234 |
| WILL %R | -92.308▼ | -87.805▼ | -92.188▼ | -40.927 | -64.271 |
| CCI | -120.000▼ | -65.367 | -76.265 | 23.840 | -40.167 |
| CDL | $ACOR Doji Candlestick Pattern Detected | Set Alert |
|
Monday, March 18, 2019 03:11 PM
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
|
|
Monday, March 18, 2019 02:38 PM
Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/03/19 | 14.40 | 14.71 | 14.28 | 14.35 | 726,772 |
| 18/03/19 | 14.66 | 14.96 | 14.30 | 14.39 | 661,333 |
| 15/03/19 | 14.68 | 14.90 | 14.59 | 14.63 | 1,411,294 |
| 14/03/19 | 14.42 | 14.70 | 14.30 | 14.60 | 642,914 |
| 13/03/19 | 14.01 | 14.58 | 13.93 | 14.47 | 660,687 |
| 12/03/19 | 13.63 | 14.15 | 13.58 | 13.93 | 483,803 |
| 11/03/19 | 13.53 | 13.61 | 12.82 | 13.58 | 1,099,140 |
| 08/03/19 | 13.69 | 13.85 | 13.40 | 13.51 | 674,945 |
| 07/03/19 | 13.535 | 14.02 | 13.51 | 13.865 | 548,730 |
| 06/03/19 | 14.30 | 14.30 | 13.75 | 13.81 | 514,203 |
|
|
||||
|
|
||||
|
|
||||
|
|